
Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform
MacDonald, Lisa D., MacKay, Alecia, Kaliaperumal, Valarmathy, Weir, Genevieve, Penwell, Andrea, Rajagopalan, Rajkannan, Langley, Joanne, Halperin, Scott, Mansour, Marc, Stanford, Marianne M.Langue:
english
Journal:
Human Vaccines & Immunotherapeutics
DOI:
10.1080/21645515.2017.1375637
Date:
September, 2017
Fichier:
PDF, 925 KB
english, 2017